Farmacologia y Toxicologia

Conference series organizing “14th International Conference on Biosimilars and Pharma Innovations” which is in February 25-26, 2021 Webinar. Theme - “New innovations in the field of Biosimilars and Pharmacology”.

This gathering plays an overall stage for medication organizations, new businesses, clinical exploration divisions, experts, pros, advisors, specialists, researchers and understudies to outline new relationship and fortify the Knowledge. Conference Series organizes the 14th International Conference on Biosimilars and Pharma Innovations (World Biosimilars 2021) which focuses mainly on the present health scenario of neonates and their developmental conditions. World Biosimilars 2021is reviewed the new findings and advancements within the field of pharmacology. This event will be of special interest to any professional involved in pediatric health care domain, such as, Professors, Associate Professors, Assistant Professors, PhD Scholars, scientists, Manufacturing Companies and their effect. World Biosimilars 2021will be organized with the theme “New innovations in the field of Biosimilars and Pharmacology” on February 25-26, 2021| Webinar

The conference focuses on the latest trends and advancements and developments in the pharmaceutical industry which focuses mainly to enrich lives. Pharmacology is the study of drug action. It involves looking at the interaction of chemical substances with the systems in our bodies, as well as identifying ways in which our biological systems affect drugs. The Organizing Committee is delighted to invite you to attend the 14th World Biosimilars Conference one of its remarkable Pharmaceutical conferences, to be held during February 25-26, 2021. World Biosimilars 2021 is a global annual event. This World Biosimilars 2021 will bring together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.

At Euro Biosimilars 2021 meet your target audiences from around the world focused on learning about biologics and Biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and Biosimilars community.

2021 Highlights:

• 10+ Keynote Speakers

• 15+ Plenary Speakers

• 2+ Exhibitors

• 14 Innovative Educational Sessions

• 1+ Workshop

• B2B Meetings

World Biosimilars 2021 has everything you need:

• Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in Biosimilars & Biologics, where all attendees can interact with the panel followed by a Q&A session.

• Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

• Editorial board meeting: Discussing on growth and development of open access Bioanalysis and Biomedicine International Journals and recruiting board members and reviewers who can support the journal.

• Round table meetings: Providing a platform where industry professionals meet academic experts.

• Over 50+ organizations and international pavilions will be exhibiting at the World Biosimilars 2021 conference. . Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The World Biosimilars 2021 has everything you need, all under one roof. It is the event you cannot afford to miss! The Conference plays a Global flat form for professionals, teachers, students, doctors , researchers etc., and the conference gives the more knowledge from the current research program which tells about the different techniques so that it is more useful for the Current research programs. With individuals from everywhere throughout the world concentrated on getting new ideas concerning Biosimilars, Pharmaceutical and its advances, this is the best chance to accomplish the greatest get-together of people from the Biosimilars and Pharma Innovation groups. Famous speakers, quality presentations, recent frameworks, novel techniques for the innovation in the field of Biosimilars and Pharmaceutics, recent techniques will mark the uniqueness of this conference. It will also pave way for making a good relationship with the Biosimilars and Pharma associates through the B2B meetings and develop better business opportunities.

All these were published in the journals of Cardiovascular Pharmacology: Open Access i.e., Journal of Clinical & Experimental Pharmacology, Biochemistry & Pharmacology: Open Access, Pharmaceutical Analytica Acta.

Conference Highlights:

• Pharmacology

• Pharmaceutics

• Consequences of Brexit on Biosimilars

• BCS and IVIVC Based Biowaivers

• Emerging Biosimilars in Therapeutics

• Drug Formulation

• Regulatory Updates on Biosimilars

• Biopharmaceutical Informatics

• Legal Issues and BPCI Act

• Pharmaceutical Chemistry

• Pharmaceutical Manufacturing

Supporting Journals:

• Journal of In Silico & In Vitro Pharmacology

• Clinical Pharmacology & Biopharmaceutics

35723